Tissue Dynamic News Today

/PRNewswire/ -- Tissue Dynamics, a disruptive AI/ML biopharma company, announced today that Prof. Roger D. Kornberg, renowned biochemist and professor of...

Tissue Dynamics Ltd., an Israeli biotechnology company, says it can cut drug development cost by 40% to 80% and the time required by 30% to 50%.

 E-Mail A team of researchers led by Professor Yaakov Nahmias, director of the Grass Center for Bioengineering at the Hebrew University of Jerusalem and founder of Tissue Dynamic, introduced a new technological approach that has the potential to rapidly develop new drugs without the need for animal experiments. According to Professor Nahmias, "Drug development is a long and expensive endeavor that is defined by multiple failures. The main reason for this failure is that clinical experiments ar...

Groundbreaking technology has the potential to significantly reduce testing and production time for new drugs while weaning science of dependence on animal testing